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Crosslinking of the immunoglobulin receptor FcεRI
activates basophils andmast cells to induce immedi-
ate and chronic allergic inflammation. However, it re-
mains unclear how the chronic allergic inflammation
is regulated. Here, we showed that ecto-nucleotide
pyrophosphatase-phosphodiesterase 3 (E-NPP3),
also known as CD203c, rapidly induced by FcεRI
crosslinking, negatively regulated chronic allergic
inflammation. Basophil and mast cell numbers
increased in Enpp3/ mice with augmented serum
ATP concentrations. Enpp3/ mice were highly
sensitive to chronic allergic pathologies, which
was reduced by ATP blockade. FcεRI crosslinking
induced ATP secretion from basophils and mast
cells, and ATP activated both cells. ATP clearance
was impaired in Enpp3/ cells. Enpp3/P2rx7/
mice showed decreased responses to FcεRI cross-
linking. Thus, ATP released by FcεRI crosslinking
stimulates basophils and mast cells for further acti-
vation causing allergic inflammation. E-NPP3 de-
creases ATP concentration and suppresses basophil
and mast cell activity.
INTRODUCTION
Basophils andmast cells are distinct cell lineages, but they share
some phenotypic and functional properties (Karasuyama et al.,
2011; Voehringer, 2013). For example, both basophils and
mast cells are activated upon crosslinking of FcεRI with anti-
gen-bound IgE to mediate type 2 immune responses against
pathogens such as helminths and ticks (Abraham and St John,
2010; Karasuyama et al., 2011). In addition, these two cell types
induce pathologic responses to allergens, composed of immedi-
ate and chronic responses.CD203c was identified as a highly expressed molecule on
activated basophils (Bu¨hring et al., 2001) and is now considered
a good biomarker candidate for the diagnosis of allergic dis-
eases (Bu¨hring et al., 2004). CD203c is a member of the ecto-
nucleotide pyrophosphatase-phosphodiesterase (E-NPP) family
consisting of seven structurally related molecules that hydro-
lyze pyrophosphate and phosphodiester bonds in various sub-
strates (Schetinger et al., 2007; Stefan et al., 2005; Yegutkin,
2008). Among seven family members, E-NPP1, E-NPP2 (also
called autotaxin), and E-NPP3 (CD203c) are closely related
in structure and hydrolyze nucleotides (Bollen et al., 2000).
E-NPP1 was shown to generate pyrophosphate through NTP
hydrolysis and thereby inhibit bone mineralization (Hessle
et al., 2002; Okawa et al., 1998). E-NPP2 acts as lysophos-
pholipase-D, which hydrolyzes lysophosphatidylcholine into
lysophosphatidic acid, thereby mediating several biologic
responses such as lymphocyte transmigration and vascular
development (Kanda et al., 2008; Umemoto et al., 2011; van
Meeteren et al., 2006). In contrast to E-NPP1 and E-NPP2,
whose functions are well characterized, the function of E-
NPP3 (CD203c) remains undetermined despite its high expres-
sion in activated basophils.
Extracellular adenosine 50-triphosphate (ATP) is released dur-
ing inflammation and activates immune cells (Idzko et al., 2014;
Junger, 2011). Several lines of evidence demonstrated that
extracellular ATP activates mast cells via the purinoreceptor
P2X7 (Kurashima et al., 2012, 2014; Sudo et al., 1996). In addi-
tion, several types of cells including mast cells release ATP
upon stimulation (Junger, 2011; Wang et al., 2013). Thus, extra-
cellular ATP modulates mast cell activity in an autocrine manner.
However, it remains unclear how ATP-dependent mast cell re-
sponses are regulated. In addition, it should also be determined
whether extracellular ATP acts on basophils, which share several
immunological functions with mast cells.
In this study, we analyzed the physiological function of E-
NPP3 (CD203c), which was highly expressed in activated baso-
phils and mast cells. In Enpp3/ mice, the activity of basophils
and mast cells was markedly enhanced with increased ATP
concentrations. Accordingly, Enpp3/ mice were susceptibleImmunity 42, 279–293, February 17, 2015 ª2015 Elsevier Inc. 279
to chronic allergic pathologies mediated by basophils and mast
cells. The crosslinking of FcεRI by IgE induced the secretion of
ATP from basophils and mast cells, and ATP clearance activity
was impaired inEnpp3/ basophils andmast cells. Extracellular
ATP and FcεRI crosslinking strongly activated Enpp3/ baso-
phils and mast cells, which was reduced by the addition of
P2X7 antagonists or introducing P2rx7 deficiency. Non-hydro-
lyzable ATP activated basophils and mast cells from wild-type
mice to similar levels observed in Enpp3/ cells. These findings
demonstrate that extracellular ATP induced by FcεRI crosslink-
ing is a potent activator of basophils and mast cells that mediate
the chronic phases of allergic responses and that E-NPP3 mod-
ulates ATP-mediated allergic responses.
RESULTS
Increased Numbers of Basophils and Mast Cells in
Enpp3–/– Mice
Activated human basophil were reported to express high
amounts of E-NPP3 (CD203c), encoded by Enpp3 (Bu¨hring
et al., 2001, 2004). Surface expression of E-NPP3 was rapidly
induced on mouse bone-marrow-derived basophils sensitized
with anti-dinitrophenyl (DNP) IgE and then stimulated with
DNP-human serum albumin (HSA) for 30 min (Figure 1A). Simi-
larly, bone-marrow-derived mast cells showed enhanced
expression of surface E-NPP3 after 30 min of crosslinking of
FcεRI by DNP-specific IgE (Figure 1B).
To analyze the in vivo function of E-NPP3, we generated mice
lacking Enpp3 by gene targeting (Figures S1A and S1B). The
targeted disruption of Enpp3 was confirmed by mRNA and pro-
tein assay (Figures S1C and S1D). Enpp3/ mice were born
and grew healthily with no alteration in the numbers of periph-
eral lymphocytes, eosinophils, and neutrophils (Figures S1E
and S1F) or CD49b+FcεRI+ basophils in bone marrow (Fig-
ure 1C). However, frequencies and numbers of CD49b+FcεRI+
basophils were markedly increased in the peripheral blood
and spleen of Enpp3/ mice compared with wild-type mice
(Figure 1D). In addition, increased frequencies and numbers of
c-kit+FcεRI+ mast cells were observed in the small and large
intestines of Enpp3/ mice (Figure 1E). In parallel with the
increased number of basophils and mast cells, serum IgE
concentration was increased in Enpp3/ mice (Figure 1F). To
determine whether the increased number of basophils and
mast cells was caused by abnormalities in hematopoietic or
non-hematopoietic cells, we generated bone marrow chimeric
mice. In wild-type mice transferred with Enpp3/ bone marrow
cells, both basophil and mast cell populations increased, but
not in Enpp3/ mice transferred with wild-type bone marrow
cells, indicating that ENPP-3 deficiency affected the hematopoi-
etic cell compartment leading to the increased number of baso-
phils and mast cells (Figures S1G and S1H) Thus, Enpp3/
mice showed the increased number of basophils and mast cells
in the periphery.
Enhanced Chronic Allergic Inflammation in
Enpp3–/– Mice
Mast cells are critical mediators of immediate hypersensitivity
reactions. Accordingly, we first examined the sensitivity of
Enpp3/ mice to passive cutaneous anaphylaxis (Obata et al.,280 Immunity 42, 279–293, February 17, 2015 ª2015 Elsevier Inc.2007). Mice were sensitized with trinitrophenyl (TNP)-specific
IgE intradermally followed by intravenous challenge with TNP-
ovalbumin (OVA) and Evans blue dye (Figure 2A). Both wild-
type and Enpp3/ mice showed similar extravasation of the
dye, indicating that immediate allergic response remains unal-
tered in the absence of Enpp3.
Basophils mediate chronic allergic inflammation in ear skin
(Mukai et al., 2005). Therefore, we analyzed the sensitivity of
Enpp3/ mice to basophil-dependent allergic inflammation.
Mice were sensitized with TNP-specific IgE and then intrader-
mally challenged with TNP-OVA (Figure S2). BALB/c back-
ground wild-type mice exhibited ear swelling (Figures 2B and
2C) accompanied by the increased infiltration of basophils,
eosinophils, and neutrophils at 4 days after antigen challenge
(Figures 2D and 2E). Enpp3/ mice showed more severe ear
swelling with increased numbers of infiltrating basophils, eosin-
ophils, and neutrophils compared with wild-type mice. Thus, the
basophil-dependent chronic allergic inflammation was exacer-
bated in Enpp3/ mice.
We next analyzed the sensitivity of Enpp3/ mice to
allergen-induced diarrhea (Brandt et al., 2003). Mice were sensi-
tized with OVA+alum twice then orally challenged with OVA
every other day, and their weight was monitored (Figure S3A).
Compared with wild-type mice, Enpp3/ mice suffered from
greater weight loss (Figure 3A). After ten times of OVA chal-
lenge, we analyzed the colon by histopathology (Figures 3B
and 3C). In Enpp3/ mice, the colon length was shortened
and more severe intestinal pathology was observed. Infiltration
of mast cells into the intestine was increased in Enpp3/ mice
(Figure 3D). Flow cytometric analysis also indicated that mast
cell populations in the small and large intestines were increased
in OVA-sensitized Enpp3/ mice compared to controls (Fig-
ures 3E and S3B). We measured serum concentrations of ATP
in mice challenged with OVA (Figure 3F). Serum ATP concentra-
tion was significantly elevated in Enpp3/ mice compared with
wild-type mice. In OVA-challenged Enpp3/ mice, IL-4 pro-
duction from CD4+ T cells in the small intestine, large intestine,
and mesenteric lymph nodes was increased (Figures 3G and
S3C). In addition, serum IgE concentrations were augmented
in OVA-challenged Enpp3/ mice (Figure 3H), indicating
enhanced Th2-cell-type responses in OVA-sensitized Enpp3/
mice. Thus, Enpp3/ mice developed severe allergic intestinal
inflammation with a dramatic increase in mast cell populations.
Because serum ATP concentrations were elevated in Enpp3/
mice, we analyzed whether severe allergic inflammation in
Enpp3/ mice was caused by elevated ATP levels by treating
mice with oxidized ATP (oATP), which blocks ATP actions by
antagonizing the ATP sensor P2X7 (Figures 3E, 3G, and 3H).
Treatment with oATP substantially reduced the number of
mast cells and IL-4-producing CD4+ T cells as well as
serum IgE concentrations in OVA-sensitized Enpp3/ mice.
These findings indicate that the severe allergic inflammation
observed in Enpp3/ mice was attributed to increased ATP
concentrations.
We also investigated a chronic asthma model. Mice were
sensitized with OVA+alum twice and then intranasally chal-
lengedwith OVA six times (Figure S4). Enpp3/mice were high-
ly sensitive to OVA-induced inflammation and almost all mutant
mice died after OVA challenge (Figure 4A). Histopathological
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Figure 1. Increased Numbers of Peripheral Basophils and Mast Cells in Enpp3–/– Mice
(A and B) Bone-marrow-derived basophils (A) andmast cells (B) were stimulated by FcεRI crosslinking using anti-DNP-IgE and DNP-HSA for 30min and analyzed
for surface E-NPP3 expression by flow cytometry. Solid line, IgE+DNP; dashed line, IgE; gray histogram, non-stimulated control. Data are representative of five
independent experiments.
(C and D) Frequencies of basophils in bone marrow (C) and the peripheral blood and spleen (D) from wild-type (WT) and Enpp3/mice were determined by flow
cytometry. Live CD3–CD4–CD8–B220– cells were gated and analyzed for expression of FcεRI and CD49b. Representative dot plots (left) and the means ± SD of
total numbers of FcεRI+CD49b+ cells from five mice (right) are shown. *p < 0.05.
(E) Frequencies of mast cells in the small and large intestines were determined by flow cytometry. Live CD3–CD4–CD8–B220– cells were gated and analyzed for
expression of FcεRI and c-kit. Representative dot plots (left) and the means ± SD of total numbers of FcεRI+c-kit+ cells from five mice (right) are shown. *p < 0.05.
(F) Concentration of serum IgE was measured. Data are means ± SD (n = 5). *p < 0.05.
See also Figure S1.analysis of the lung revealed infiltration of increased number of
inflammatory cells and enhanced mucus production in OVA-
challenged Enpp3/ mice (Figures 4B and 4C). Basophil popu-
lations in the peripheral blood and the lung increased and serum
IgE concentrations were augmented in Enpp3/ mice (Figures4D and 4E). Serum ATP concentrations were also elevated in
Enpp3/mice challenged with OVA (Figure 4F). oATP treatment
ameliorated OVA-induced inflammation and reduced basophil
populations and serum IgE levels in Enpp3/ mice (Figures
4A, 4D, and 4E). Taken together, these findings indicate thatImmunity 42, 279–293, February 17, 2015 ª2015 Elsevier Inc. 281
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Figure 2. The Enpp3 Deficiency Exacerbates Basophil-Dependent Allergic Inflammation
(A) Anti-TNP IgE-sensitized WT and Enpp3/ mice were intravenously challenged with TNP-OVA and Evans blue. At 30 min after the challenge, extravasated
dyes in the ear skin were measured by spectrophotometry. Data are shown as means ± SD (n = 5). **p < 0.01, ns: not significant.
(B) Thickness of ears from anti-TNP IgE-sensitized WT and Enpp3/ mice were measured daily after subcutaneous challenge with TNP-OVA or OVA. Data are
shown as means ± SD (n = 7). *p < 0.05.
(C) Ear specimens fromWT and Enpp3/mice were histologically analyzed with Giemsa staining 4 days after antigen challenge. Black arrows indicate infiltrated
eosinophils containing red-colored granules. Data are representative of five mice examined.
(D and E) Frequencies (D) and numbers (E) of basophils (CD3–CD4–CD8–B220–FcεRI+CD49b+), eosinophils (CD3–CD4–CD8–B220–Siglec-F+LPAM-1+),
and neutrophils (MHC class II–Ly6G+CD11b+) were determined by flow cytometry and cell counting with trypan blue. Data in (E) are means ± SD (n = 5). *p < 0.05,
**p < 0.01.
See also Figure S2.
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E-NPP3 is required for the suppression of chronic allergic inflam-
mation by the downregulation of ATP concentration.
Defective ATP Clearance of Enpp3–/– Basophils and
Mast Cells
Crosslinking of FcεRI by DNP-specific IgE induced the produc-
tion of cytokines such as IL-4 and IL-6 from basophils and mast
cells, respectively (Figure 5A). IgE-dependent cytokine produc-
tion was enhanced in Enpp3/ cells. Activated mast cells
show increased Ki-67 expression (Abraham and St John,
2010; Bischoff et al., 1999). Therefore, we analyzed Ki-67
expression in basophils and mast cells stimulated with FcεRI
crosslinking (Figure 5B). The FcεRI crosslinking-dependent in-
crease in Ki-67 staining was enhanced in Enpp3/ mast cells
and basophils. Thus, Enpp3/ basophils and mast cells were
highly activated.
Several cell types secrete ATP upon stimulation (Corriden and
Insel, 2010; Junger, 2011). Therefore, basophils and mast cells
were stimulated with DNP-specific IgE for 1 hr and analyzed
for ATP release (Figure 5C). FcεRI crosslinking of wild-type baso-
phils and mast cells induced the release of substantial amounts
of ATP, and ATP concentrations in supernatants of stimulated
Enpp3/ cells were markedly increased compared with that in
wild-type cells. We then analyzed whether increased ATP con-
centrations in stimulated Enpp3/ cells was due to defective
ATP clearance. Basophils and mast cells were stimulated by
FcεRI crosslinking for the indicated periods and ATP concentra-
tions in supernatants were measured (Figure S5A). At 15 min af-
ter stimulation, ATP concentrations were comparable between
wild-type and Enpp3/ cells, indicating that FcεRI-dependent
ATP release at the early phase of stimulation was not affected
in Enpp3/ cells. However, at 30 and 60 min after stimulation,
ATP concentrations were increased in Enpp3/ cells compared
with wild-type cells. We next added exogenous ATP into the
basophil and mast cell culture and measured inorganic phos-
phate (Pi) and inorganic pyrophosphate (PPi), produced by hy-
drolysis of ATP to ADP and ATP to AMP, respectively (Figures
5D and S5B). In the supernatants of wild-type basophils and
mast cells, free Pi and PPi increased after the addition of exog-
enous ATP, indicating that wild-type cells have potent ATP
hydrolyzing activity. However, increase in Pi and PPi concentra-
tions was substantially dampened in the supernatants of
Enpp3/ cells. These findings indicate that ATP clearance ac-Figure 3. The Enpp3 Deficiency Aggravates Allergic Intestinal Inflamm
(A) Body weights of OVA-sensitized WT (n = 7) and Enpp3/ (n = 7) mice with
*p < 0.05.
(B) Colon length of WT (n = 7) and Enpp3/ (n = 7) mice were measured after ten
are means ± SD. *p < 0.05.
(C and D) Colons were sectioned and stained with H&E (C) or Toluidine blue (D). Bla
(E) Mast cells frequencies in small (SI) and large (LI) intestines of OVA-challengedW
were determined by flow cytometry. Means ± SD are shown. *p < 0.05.
(F) Serum ATP concentrations from non-treated WT (n = 8), Enpp3/ (n = 8), O
measured. Data are means ± SD. **p < 0.01.
(G) Cells isolated from small intestine (SI), large intestine (LI), and mesenteric lym
Enpp3/mice (n = 5) after 10 times OVA administration were stained for intracell
are shown. *p < 0.05.
(H) Serumconcentrations of IgE in non-treatedWT (n = 8),Enpp3/ (n = 8), OVA-c
(n = 7) oATP treatment were measured. Data are means ± SD. *p < 0.05.
See also Figure S3.
284 Immunity 42, 279–293, February 17, 2015 ª2015 Elsevier Inc.tivity was impaired in basophils and mast cells derived from
Enpp3/ mice.
We also assessed the ATP clearance activity in vivo. Wild-type
and Enpp3/ mice were intravenously injected with ATP, and
at the indicated time points serum was taken to analyze the
levels of ATP and PPi. Serum ATP concentration was higher at
any time points in Enpp3/ mice (Figure S5C). In addition, at
2 and 4 hr after the administration, fold-increase of ATP concen-
tration compared to the basal concentration was markedly
elevated in Enpp3/ mice. However, the fold change at 6 hr
time point showed similar pattern between wild-type and
Enpp3/mice (Figure S5D). The concentration of PPi was lower
at 1 hr in Enpp3/mice, but later elevated to the similar concen-
tration as that of wild-type mice (Figure S5E). These findings
indicate that kinetics of the ATP clearance in vivo was delayed
in Enpp3/ mice, resulting in the increased serum ATP
concentration.
Enhanced ATP Responses in Enpp3–/– Mice
Because extracellular ATP activates mast cells (Kurashima et al.,
2012, 2014; Sudo et al., 1996), we analyzed ATP responses
of basophils and mast cells. Culture of wild-type basophils
and mast cells in the presence of exogenous ATP led to the
secretion of IL-4 and IL-6, respectively (Figure 5E). ATP-induced
cytokine production wasmarkedly augmented inEnpp3/ cells.
ATP also increased the number of Ki-67-positive basophils
and mast cells from wild-type mice, and this was substantially
enhanced in Enpp3/ cells (Figure 5F). Thus, Enpp3/
basophils and mast cells showed enhanced ATP-dependent
responses.
Next, we assessed whether the enhanced ATP responses
were due to the defective clearance of extracellular ATP in
Enpp3/ basophils and mast cells by stimulating cells with a
non-hydrolyzable ATP, ATPgS (Figure 5F). In wild-type basophils
and mast cells, ATPgS increased Ki-67 expression compared
with ATP, and their levels were comparable to those of ATPgS-
stimulated Enpp3/ cells. We also analyzed in vivo ATP re-
sponses. ATP or ATPgS was intravenously injected to mice
over three consecutive days and the Ki-67 expression in baso-
phils was assessed (Figure 5G). Almost all blood basophils
from Enpp3/ mice were Ki-67 positive, indicating that
Enpp3/ basophils were highly activated. In contrast, about
50% of basophils in the peripheral blood of wild-type miceation
intragastric challenge with OVA. Data are baseline weights and means ± SD.
times OVA administration. Representative pictures are shown (left). Data (right)
ck arrows indicate mast cells. Data are representative of threemice examined.
Tmice (n = 5) and Enpp3/mice with (n = 5) or without (n = 5) oATP treatment
VA-challenged WT (n = 7), and OVA-challenged Enpp3/ (n = 7) mice were
ph nodes (MLNs) of WT mice (n = 5), Enpp3/ mice (n = 5), and oATP-treated
ular IL-4 in CD4+ cells. Means ± SD of the percentage of IL-4+ cell in CD4+ cells
hallengedWT (n = 7), andOVA-challenged Enpp3/micewith (n = 5) or without
A B
D
C
E F
Figure 4. High Sensitivity to Chronic Airway Inflammation in Enpp3–/– Mice
(A) Survival rates of WT (n = 7), Enpp3/ (n = 10), and Enpp3/ mice with oATP treatment (n = 5) after OVA challenge are shown.
(B and C) Lungs were sectioned and stained with H&E (B) or Alcian blue (C). Data are representative of three mice examined.
(D) Frequencies of basophils, eosinophils, and neutrophils in the peripheral blood and lung were measured by flow cytometry. Representative dot plots of WT
(n = 5), Enpp3/ (n = 3), and Enpp3/ mice with oATP treatment (n = 3) are shown.
(E and F) Concentrations of serum IgE (E) and ATP (F) at 32 days after OVA challenge were determined by ELISA and a luciferin-luciferase assay, respectively. The
means ± SD are shown. Non-treated WT (n = 7), Enpp3/ (n = 7), OVA-challenged WT (n = 7), and OVA-challenged Enpp3/mice with (n = 5) or without (n = 7)
oATP treatment. *p < 0.05, **p < 0.01.
See also Figure S4.were Ki-67 positive. ATP injection only moderately increased the
number of Ki-67-positive basophils in the peripheral blood of
wild-type mice, but almost all wild-type basophils were Ki-67
positive after ATPgS injection. We also analyzed mast cell pop-
ulations in the small and large intestines after the intravenous in-jection of ATP or ATPgS (Figure 5H). ATP only slightly increased
mast cell frequencies in wild-type mice, but ATPgS substantially
increased the frequency of wild-type mast cells to similar levels
of mast cells in Enpp3/ mice. Taken together, these findings
indicate that extracellular ATP activates basophils andmast cellsImmunity 42, 279–293, February 17, 2015 ª2015 Elsevier Inc. 285
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and that E-NPP3 modulates ATP-induced responses through
ATP degradation.
We next investigated whether the ATP-dependent increase of
basophils and mast cells was attributable to increased prolifera-
tion or decreased apoptosis. Basophils and mast cells were
treated with ATP, and proliferative activity and apoptotic cell
number in vitro were analyzed by measuring 3H-thymidine up-
take and annexin-V-positive cells, respectively (Figures S5F
and S5G). ATP induced growth of wild-type basophils and
mast cells only marginally. However, Enpp3/ basophils and
mast cells showed vigorous proliferation in response to ATP.
ATP inhibited apoptosis marginally in wild-type basophils and
moderately in wild-type mast cells. ATP-mediated suppression
of apoptosis was not dramatically altered in Enpp3/ mice.
Thus, in the absence of Enpp3, proliferative activity of basophils
and mast cells was enhanced, which might result in increased
number of peripheral basophils and mast cells.
Regulation of Autocrine ATP-Dependent Activation by
E-NPP3
Extracellular ATP activates ERK1 and/or ERK2 (ERK1/2) to
induce cellular responses (Shiratori et al., 2010; Swanson
et al., 1998). Therefore, we analyzed ATP-induced phosphory-
lation of ERK1/2 in basophils and mast cells (Figure 6A). Phos-
phorylation of ERK1/2 was induced by 15 min of ATP stimulation
in wild-type basophils and mast cells and ATP-induced phos-
phorylation of ERK1/2 was enhanced in Enpp3/ cells
compared with wild-type cells. ATP-induced ERK1/2 phosphor-
ylation was inhibited by oATP pretreatment. FcεRI crosslinking
also induced ERK1/2 phosphorylation. At 15 min after FcεRI
crosslinking, phosphorylation of ERK1/2 was similarly induced
in wild-type and Enpp3/ basophils and mast cells (Figure 6B).
Pretreatment with oATP did not decrease the ATP-induced
ERK1/2 phosphorylation, indicating that FcεRI crosslinking
directly induced ERK activation. At 60 min after crosslinking,
the amount of ERK1/2 phosphorylation was reduced in wild-
type basophils and mast cells compared with those observed
at 15 min. However, ERK1/2 phosphorylation remained at a
high level in Enpp3/ cells even at 60min after crosslinking (Fig-
ure 6C). Because FcεRI crosslinking induces the secretion of
ATP and ATP activates ERK1/2, we analyzed the involvement
ATP in sustained ERK1/2 phosphorylation in Enpp3/ cells atFigure 5. Defective ATP Clearance of Enpp3–/– Basophils and Mast Ce
(A) Bone-marrow-derived basophils (left) and mast cells (right) from WT mice an
centrations of IL-4 and IL-6 in culture supernatants were measured.
(B) Basophils (left) andmast cells (right) fromWT and Enpp3/mice were stimula
determined by flow cytometry.
(C) Basophils (left) and mast cells (right) of WT and Enpp3/ mice were stimula
pernatants were measured.
(D) Basophils andmast cells were incubated for 60min in the presence of ATP (100
the supernatants were measured.
(E) Basophils (left) andmast cells (right) fromWT and Enpp3/mice were cultured
culture supernatants were measured.
(F) Basophils (left) andmast cells (right) fromWT andEnpp3/micewere stimulat
determined by flow cytometry.
(G and H) WT mice were administrated PBS, ATP, or ATPgS. Enpp3/ mic
CD3–CD4–CD8–B220– cells was analyzed (G). Frequencies of c-kit+FcεRI+ mas
cytometry (H).
Data are means ± SD of five independent experiments; *p < 0.05 (A–F). Data are rthe later time point of FcεRI crosslinking, by pretreating cells
with oATP. oATP pretreatment did not induce changes in
ERK1/2 phosphorylation of wild-type cells. In contrast, oATP
pretreatment substantially reduced ERK1/2 activation. This
was in accordance with the observations that ATP activated
ERK and that ATP- and FcεRI crosslinking-dependent cellular
activation of Enpp3/ basophils and mast cells was reduced
by treatment with the ERK inhibitor U0126 (Figures S6A–S6D).
These findings indicate that ATP released by FcεRI crosslinking
acts on basophils and mast cells in an autocrine manner to
further activate the cells and that E-NPP3 negatively regulates
ATP-dependent cellular activation.
In order to confirm the autocrine effect of ATP on basophils
and mast cells, we co-cultured CD45.2 Enpp3/ basophils
and mast cells with CD45.1 wild-type cells. ATP- or FcεRI cross-
linking-induced increase of Ki-67 expression was considerably
enhanced in Enpp3/ basophils and mast cells compared
to wild-type cells (Figure 6D). Furthermore, in basophils and
mast cells with siRNA-mediated reduced Enpp3 expression,
ATP- and FcεRI crosslinking-induced cytokine production was
increased (Figures 6E and S6E). Thus, the enhanced ATP
response of basophils and mast cells in the absence of Enpp3
is intrinsic to these cells. Taken together, these finding demon-
strate that E-NPP3 suppresses the autocrine effect of ATP of
basophils and mast cells.
P2X7-Dependent Activation of Basophils andMast Cells
ATP activates mast cells via the purinoreceptor P2X7 (Kura-
shima et al., 2012, 2014; Sudo et al., 1996). Because basophil-
and mast cell-dependent chronic inflammation in Enpp3/
mice was ameliorated by oATP treatment, which antagonizes
P2X7 actions (Figures 3 and 4), we analyzed whether overacti-
vation of Enpp3/ basophils and mast cells was mediated by
P2X7 by using another P2X7 selective antagonist, A839977
(Figure 7A). FcεRI crosslinking markedly augmented the num-
ber of Ki-67-positive basophils and mast cells in Enpp3/
mice, which was reduced by pretreatment with oATP. The se-
lective P2X7 antagonist A839977 also reduced the number of
Ki-67-positive cells in Enpp3/ mice. The enhanced produc-
tion of IL-4 and IL-6 from FcεRI-stimulated basophils and
mast cells was also decreased by pretreatment with A839977
and oATP (Figure 7B). Thus, experiments with P2X7 receptorlls
d Enpp3/ mice were stimulated with FcεRI crosslinking for 24 hr, and con-
ted with FcεRI crosslinking for 24 hr. The percentage of Ki-67-positive cells was
ted with FcεRI crosslinking for 1 hr, and concentrations of ATP in culture su-
mMor 1mMfinal concentration). Concentrations of pyrophosphate (free PPi) in
in the presence of 100 mMATP for 24 hr, and concentrations of IL-4 and IL-6 in
edwith 1 mMATPor ATPgS for 24 hr. The percentage of Ki-67-positive cells was
e were administered PBS. Expression of c-kit, FcεRI, and Ki-67 in blood
t cells in small (SI) and large intestines (LI) of mice were determined by flow
epresentative of three independent experiments (G and H). See also Figure S5.
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Figure 6. ATP-Dependent Overactivation of ERK1/2 in Enpp3–/– Basophils and Mast Cells
(A) Cell lysates were prepared from bone-marrow-derived basophils (upper) and mast cells (lower) fromWT and Enpp3/mice pretreated with 300 mMoATP for
3 hr and then stimulated by 100 mMATP for 15 min. Expression of phospho-ERK1/2 and ERK1/2 were determined by immunoblotting. Data are representative of
five independent experiments.
(B and C) Cell lysates were prepared from bone-marrow-derived basophils (upper) andmast cells (lower) of WT and Enpp3/mice pretreated with 300 mMoATP
for 3 hr and then stimulated by anti-DNP-IgE and DNP-HSA for 15 min (B) or 60 min (C). The levels of phospho-ERK1/2 and ERK1/2 were determined by
immunoblotting. Data are representative of three independent experiments.
(legend continued on next page)
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antagonists suggested that P2X7 mediates the overactivation
of Enpp3/ basophils and mast cells. We next introduced
the P2rx7 deficiency into Enpp3/ mice. In P2rx7/ and
Enpp3/P2rx7/ basophils and mast cells, ATP-dependent
cytokine production was severely reduced (Figure 7C). Further-
more, FcεRI crosslinking-induced increase of cytokine produc-
tion was decreased in Enpp3/P2rx7/ basophils and mast
cells compared with Enpp3/ cells (Figure 7D). In addition,
the number of basophils in the peripheral blood and spleen
as well as mast cells in the small and large intestines was
also reduced in Enpp3/P2rx7/ mice compared with
Enpp3/ mice (Figure 7E). Thus, introduction of the P2rx7 defi-
ciency into Enpp3/ mice resulted in the decreased activity of
basophils and mast cells, demonstrating that P2X7 mediates
the ATP-dependent late-phase activation of basophils and
mast cells.
DISCUSSION
E-NPP3 (also known as CD203c) is an activationmarker of baso-
phils and mast cells (Bu¨hring et al., 2001; Ghannadan et al.,
2002). In the present study, we demonstrated that E-NPP3 is a
critical negative regulator of basophils and mast cells through
the hydrolysis of extracellular ATP, an activator of mast
cells (Kurashima et al., 2012, 2014). Basophils were activated
by ATP and the overproduction of ATP enhanced chronic
allergic responses mediated by basophils and mast cells.
Thus, extracellular ATPwas demonstrated to be a potent inducer
of the chronic phase of allergic responses, and E-NPP3, which is
rapidly expressed in activated basophils andmast cells by FcεRI
crosslinking, suppresses the ATP-dependent activation by hy-
drolyzing extracellular ATP.
Several lines of evidence indicated that ATP modulates the
functions of neuronal and immune cells (Junger, 2011). ATP
is released as a danger-associated molecular pattern from
damaged and stressed cells for the clearance of these cells by
phagocytes (Elliott et al., 2009; Mariathasan et al., 2006). In addi-
tion, ATP is released from non-damaged cells by physiologic
stimuli and acts on cells in an autocrine or paracrine manner to
modulate cellular functions (Corriden and Insel, 2010). The pre-
sent study demonstrates that basophils and mast cells are acti-
vated by autocrine ATP.
An increase in extracellular ATP was reported in several in-
flammatory conditions, such as skin inflammation and asthma
(Idzko et al., 2007; Kawamura et al., 2012). In addition, the impor-
tance of ATP hydrolysis in the regulation of several types of
inflammations was demonstrated in mice deficient for CD39
(ecto-nucleoside triphosphate diphosphohydorolase) or CD73
(ecto 50-nucleotidase) (Deaglio et al., 2007; Friedman et al.,
2009; Mizumoto et al., 2002). In those studies, cells responsible
for ATP hydrolysis were T cells or dendritic or Langerhans cells.(D) Mixtures of basophils (top) and mast cells (bottom) of WT (CD45.1) and Enpp
FcεRI crosslinking for 24 hr. The percentage of Ki-67-positive cells was determi
dependent experiments. *p < 0.05.
(E) Bone-marrow-derived basophils (left) and mast cells (right) from wild-type
stimulated with ATP or FcεRI crosslinking for 24 hr. The concentrations of IL-4 a
independent experiments. *p < 0.05.
See also Figure S6.The present study demonstrated that another type of ATP-hy-
drolyzing enzyme, E-NPP3, expressed on basophils and mast
cells was responsible for the modulation of chronic allergic
inflammation via the suppression of ATP-dependent autocrine
cell activation.
Basophils and mast cells expressing FcεRI are well known to
induce immediate allergic responses through IgE-mediated
crosslinking (Gould and Sutton, 2008). In addition, recent evi-
dence indicated that chronic allergic responses are especially
induced by basophils through the FcεRI (Karasuyama et al.,
2009; Mukai et al., 2005). The present study indicates that ATP
is responsible for the pathogenesis of chronic allergic responses.
Based on the findings of the present study, we propose the
following model during immediate and chronic phases of allergic
responses mediated by basophils and mast cells. FcεRI cross-
linking induces secretion of several mediators including ATP
from basophils and mast cells, which induces the immediate
phase of allergic responses. Then, ATP acts on basophils and
mast cells in an autocrine manner to further activate basophils
and mast cells, leading to the development of chronic-phase
allergic inflammation. E-NPP3 (CD203c), which is rapidly ex-
pressed on activated basophils and mast cells, negatively regu-
lates ATP-dependent chronic responses.
In Enpp3/ mice, the number of peripheral basophils, but not
bone marrow basophils, was increased. In this regard, basophils
in the bone marrow, where basophils are generated de novo,
might be premature or many factors might contribute to the
maintenance or proliferation of basophil precursors. Indeed,
anti-basophil mAb treatment drastically reduced the number of
peripheral basophils but not bone marrow basophils (Obata
et al., 2007). Alternatively, ATP concentration in the bonemarrow
environment was not altered in Enpp3/ mice (our unpublished
results), which might be one of causes for the similar number of
bone marrow basophils in both genotypes.
It is interesting to note that the inflammatory mediator ATP
was released from basophils and mast cells by FcεRI crosslink-
ing and that the negative regulator of the ATP response, E-
NPP3, was simultaneously expressed in these cells. In this re-
gard, ATP-dependent continuous activation might be physio-
logically responsible for the efficient expulsion of helminths by
basophils and mast cells. E-NPP3, in turn, modulates excessive
ATP-dependent responses to prevent chronic allergic
disorders.
The ATP-induced activation of basophils and mast cells is
mediated by P2X7 and ERK MAP kinases. A previous study
demonstrated that P2X7-mediated sensing of ATP induced the
activation of several signal transduction pathways leading to
the activation of microglia (Shiratori et al., 2010). In the present
study, the involvement of ERK MAP kinases in the activation of
basophils and mast cells was demonstrated. However, other
signaling pathways such as p38 and JNK MAP kinases as well3/ (KO: CD45.2) mice (1:1 ratio in cell number) were stimulated with ATP or
ned by flow cytometry. Data shown in right panel are means ± SD of three in-
mice were introduced with Enpp3-specific siRNA or control siRNA and then
nd IL-6 in culture supernatants were measured. Data are means ± SD of five
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Figure 7. P2X7-Dependent Activation of Basophils and Mast Cells
(A and B) Bone-marrow-derived basophils (left) andmast cells (right) from Enpp3/mice were pretreated with 300 mMoATP or 100 nMA839977 for 3 hr and then
stimulated by anti-DNP-IgE and DNP-HSA for 24 hr. The percentage of Ki-67+ cells was determined by flow cytometry (A). Concentrations of IL-4 and IL-6 in
culture supernatants were determined by ELISA (B). Data are means ± SD of three independent experiments. *p < 0.05.
(legend continued on next page)
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as PKC might also participate in the ATP/P2X7-induced activa-
tion of basophils and mast cells.
P2X7 was shown to be responsible for the ATP-dependent
overactivation of basophils and mast cells in the absence of E-
NPP3. Indeed, several previous studies indicated that P2X7 is
implicated in the pathogenesis of airway allergic inflammation
in mice and humans (Denlinger et al., 2013; Idzko et al., 2007;
Manthei et al., 2012; Mu¨ller et al., 2011) as well as contact hyper-
sensitivity in a mouse model (Weber et al., 2010). However, all of
these studies focused on dendritic cells as a target of ATP. It is
generally considered that late-phase allergic inflammation is
mediated by Th2 cells. However, basophils and mast cells are
closely associated to Th2-cell-type responses (Karasuyama
et al., 2011; Voehringer, 2013). In addition, it was shown that
the chronic phase of IgE-dependent allergic inflammation can
be induced independently of T cells (Mukai et al., 2005). In the
present study, P2X7 on basophils and mast cells was respon-
sible for the late phase of IgE-dependent activation of basophils
andmast cells. Thus, P2X7 on basophils andmast cells could be
a possible target for the treatment of allergic diseases. However,
both P2X3 and P2X7 were highly expressed on basophils (our
unpublished results), and therefore P2X3 might also participate
in the ATP-dependent activation of basophils and mast cells.
Indeed, although ATP-dependent responses were severely
reduced, they were not completely blocked in the absence of
P2rx7. The possible involvement of P2Y receptors should also
be considered.
In the present study, we revealed that E-NPP3 is a negative
regulator of chronic allergic responses via ATP hydrolysis.
Because E-NPP3 is selectively expressed in activated basophils
andmast cells, themain cell types involved in allergic responses,
the development of a novel drug to activate or induce E-NPP3
might be beneficial for the establishment of an effective therapy
for allergic diseases, which recently have increased in number.
EXPERIMENTAL PROCEDURES
Passive Cutaneous Anaphylaxis
Wild-type and Enpp3/mice on the BALB/c backgroundwere sensitized with
100 ng anti-TNP IgE derived from IGELb4 B cell hybridoma in 10 ml PBS by in-
tradermal injection into the left ear. As a control, PBSwas injected into the right
ear. At 24 hr after the sensitization, mice were intravenously challenged with
300 mg TNP14-conjugated ovalbumin (TNP-OVA; Biosearch Technologies)
plus 2% Evans blue (Sigma-Aldrich) in 300 ml PBS. Mice were euthanized
30 min after the antigen challenge, followed by extraction of Evans blue dye
from each ear in 700 ml acetone/water (7:3) at room temperature overnight.
The absorbance at 620 nm in the extract wasmeasuredwith a spectrophotom-
eter. All animal experiments were conducted with approval of the Animal
Research Committee of the Graduate School of Medicine at Osaka University
and the Animal Care and Use Committee, The University of Tokyo.
IgE-Mediated Chronic Allergic Skin Inflammation
IgE-mediated chronic allergic skin inflammation was induced as previously
described (Mukai et al., 2005). In brief, wild-type and Enpp3/ mice on the
BALB/c background were sensitized with 200 mg anti-TNP IgE derived from(C and D) Bone-marrow-derived basophils (left) andmast cells (right) fromWT, P2r
100 mMATP (C) or anti-DNP-IgE and DNP-HSA (D) for 24 hr, and concentrations o
three independent experiments. *p < 0.05.
(E) Frequencies of basophils in peripheral blood and spleen and frequencies of m
Enpp3/P2rx7/ mice were determined by flow cytometry. Representative doIGELb4 B cell hybridoma by intravenous injection. The next day, left ears of
IgE-sensitized mice were intradermally challenged with 10 mg TNP-OVA (Bio-
search Technologies) in 10 ml PBS and right ears were inoculated an equal
amount of OVA (grade V; Sigma-Aldrich) by microsyringe. The thickness of
ears were measured by a dial thickness gauge (G-1A; Ozaki), and numbers
and frequencies of basophils (CD3–CD4–CD8–B220–FcεRI+CD49b+), eosino-
phils (CD3–CD4–CD8–B220–Siglec-F+LPAM-1+), and neutrophils (MHC class
II–Ly6G+CD11b+) in ears treated with 1 mg/ml collagenase D (Roche) were
determined by trypan blue cell counting and flow cytometry. For histological
analysis, ear specimens were fixed with 4% paraformaldehyde phosphate
buffer solution (Wako) and embedded in paraffin. Sections were stained with
Giemsa and analyzed with a BZ-9000 microscope system (Keyence).
Experimental Oral Allergen-Induced Diarrhea
Experimental oral allergen-induced diarrhea was elicited as previously
described (Brandt et al., 2003). In brief, wild-type and Enpp3/ mice were
sensitized with a mixture of 50 mg of OVA (grade V; Sigma-Aldrich) and 1 mg
of aluminum hydroxide adjuvant (Imject Alum; Thermo Scientific) twice with
a 2-week interval. At 2 weeks after the last sensitization, mice were intragastri-
cally challenged with 10 mg of OVA in 200 ml PBS every 2 days for 10 times af-
ter 3 hr of food deprivation. Body weights were recorded before intragastric
challenge. In some experiments, OVA-sensitized Enpp3/mice were intrave-
nously administrated with 100 ml of 5 mM oATP (Sigma-Aldrich) 5 times every
3 days during the period of intragastric challenge. After 10 times of OVA chal-
lenge, the mice were sacrificed and used for analyses of cell population and
histology. Peripheral blood was harvested for serum ATP measurement 1 hr
after the last intragastric challenge. For histological analysis, colon specimens
were prepared by a Swiss roll method and fixed with 4% paraformaldehyde
phosphate buffer solution (Wako) and embedded in paraffin. Sections were
stained with hematoxylin and eosin or toluidine blue and analyzed with a
BZ-9000 microscope system (Keyence).
Experimental Chronic Asthma
Chronic asthmawas induced as previously described with somemodifications
(Idzko et al., 2007; Wakahara et al., 2013). Wild-type and Enpp3/ mice were
sensitized with a mixture of 50 mg of OVA (grade V; Sigma-Aldrich) and 1 mg of
aluminum hydroxide adjuvant (Imject Alum; Thermo Scientific) twice with a 10-
day interval. Then, the OVA-sensitized mice were intranasally challenged with
50 mg of OVA in 20 ml PBS on day 17, 19, 21, 28, 30, and 32. In some experi-
ments, OVA-sensitized Enpp3/ mice were administrated 100 ml of 5 mM
oATP intravenously on day 11, 14, and 17, as well as 30 min before OVA intra-
nasal challenges. At 16 hr after the last intranasal challenge, peripheral blood
was harvested for serum ATP measurement. For histological analysis, lung
specimens were fixed with 4% paraformaldehyde phosphate buffer solution
(Wako) and embedded in paraffin. Sections were stained with hematoxylin
and eosin or Alcian blue and hematoxylin.
In Vitro Stimulation Assay
For IgE crosslinking, bone-marrow-derived basophils and mast cells were
pretreated with 1 mg/ml anti-DNP IgE (SPE-7; Sigma-Aldrich) for 6 hr, and
then stimulated with 50 ng/ml DNP-HSA (Sigma-Aldrich) for the indicated pe-
riods. In some experiments, bone-marrow-derived basophils and mast cells
were pretreated with 300 mM oATP (Sigma-Aldrich) or 100 nM A839977 P2X7
antagonist (Tocris Bioscience) for 3 hr or with 20 mM U0126 (Sigma-Aldrich)
for 1 hr.
Measurement of ATP Hydrolyzing Activity
ATP hydrolyzing activity was determined by measuring levels of free inorganic
phosphate and free inorganic pyrophosphate in the supernatants of cells
cultured for 1 hr after the addition of ATP (100 mM or 1 mM). Levels of free
inorganic phosphate and free inorganic pyrophosphate were determined byx7/, Enpp3/, and Enpp3/P2rx7/mice were cultured in the presence of
f IL-4 and IL-6 in culture supernatants were measured. Data are means ± SD of
ast cells in small (SI) and large intestines (LI) fromWT, P2rx7/, Enpp3/, and
t plots from three independent experiments are shown.
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Malachite Green Phosphate Assay Kits (BioAssay Systems) and Pyrophos-
phate Assay Kit (Fluorometric; Abcam), respectively.
Treatment with ATP and ATPgS
Mice were administrated 1 mMATP or ATPgS in 100 ml PBS intravenously (i.v.)
daily for 3 days before flow cytometric analysis.
Co-culture of Wild-Type and Enpp3–/– Basophils and Mast Cells
Bone-marrow-derived basophils and mast cells from CD45.1 wild-type and
CD45.2 Enpp3/ mice on the C57BL/6 background were mixed in 1:1 ratio
and stimulated with 100 mM ATP or treated with 1 mg/ml anti-DNP IgE (SPE-
7; Sigma-Aldrich) for 6 hr followed by stimulation with 50 ng/ml DNP-HSA
(Sigma-Aldrich). After 24 hr of the stimulation, cells were stained with anti-
CD45.1, anti-CD45.2, and anti-Ki-67 Abs.
siRNA-Mediated Knockdown of Enpp3 in Basophils and Mast Cells
Bone-marrow-derived basophils and mast cells from wild-type mice prepared
as above were introduced with Enpp3-specific siRNA (sc-142185; Santa Cruz)
or control siRNA (silencer negative control; Life Technologies) by using a Lonza
transfection system (Amaxa cell line nucleofector kit V; Lonza). At 12 hr after
the siRNA introduction, cells were analyzed for expression Enpp3 mRNA
and used for experiments.
Statistical Analysis
Differences between control and experimental groups were evaluated by the
Student’s t test. A p value < 0.05 was considered significant. Data are pre-
sented as mean ± SD.
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